Procurement Summary
Country: Serbia
Summary: Medicines Outside the List of Medicines
Deadline: 16 Apr 2026
Posting Date: 01 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138801350
Document Ref. No.: A184/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Anifrolumab, Asciminib, Avatrombopag, Azacytidine, Aztreonam, Benralizumab, Ceftolozane/Tazobactam, Dalbavancin, Dantrolene, Darolutamide, Durvalumab, Ervacycline, Escetamine, Fremanezumab, Human C1 Esterase Inhibitor for Subcutaneous Use, Human Normal Ig, Enclized, Isavuconazole, Isavuconazole, Sodium glycerol phosphate pentahydrate (1 vial contains 1 mmol/mL phosphate and 2 mmol/mL sodium)
Status of the procedure: Ordering party UNIVERSITY CLINICAL CENTER OF SERBIA Ordering location RS110 - Belgrade region, BELGRADE Procurement name Medicines outside the list of medicines Reference number A184/2026 Item type Good Estimated value Type of procedure Open procedure Deadline for submission 04/16/2026 09:00:00 Status of the procedure Published Deadline for submission: 16.04.2026 09:00:00
Documents
Tender Notice